NCT02865018View on ClinicalTrials.gov

Neuromyelitis Optica (NMO) & Cetirizine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Neuromyelitis Optica
Interventions
DRUG

cetirizine

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

Guthy Jackson Charitable Foundation

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02865018 - Neuromyelitis Optica (NMO) & Cetirizine | Biotech Hunter | Biotech Hunter